These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6113935)

  • 1. 3-O-methyl-alpha-methyldopamine, a urinary metabolite of p-methoxyamphetamine in dog and monkey.
    Hubbard JW; Bailey K; Midha KK; Cooper JK
    Drug Metab Dispos; 1981; 9(3):250-4. PubMed ID: 6113935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of 3-O-methyl-alpha-methyldopamine as a urinary metabolite of 3,4-methylenedioxyamphetamine in dog and monkey.
    Midha KK; Cooper JK; By A; Ethier JC
    Drug Metab Dispos; 1977; 5(2):143-8. PubMed ID: 15806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Methyldopamine, a key intermediate in the metabolic disposition of 3,4-methylenedioxyamphetamine in vivo in dog and monkey.
    Midha KK; Hubbard JW; Bailey K; Cooper JK
    Drug Metab Dispos; 1978; 6(6):623-30. PubMed ID: 33023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic O-demethylation of 3,4-dimethoxyamphetamine in vivo in dog and monkey.
    Midha KK; Bailey K; Cooper JK; Hubbard JW
    Xenobiotica; 1979 Aug; 9(8):485-90. PubMed ID: 117645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ibopamine metabolites in rat and dog urine.
    Kuo GY; Hwang BY; Lynn RK
    Drug Metab Dispos; 1988; 16(6):793-8. PubMed ID: 2907455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolism of p-methoxyamphetamine in dog and monkey. O-demethylation as a major route.
    Hubbard JW; Midha KK; Cooper JK
    Drug Metab Dispos; 1977; 5(4):329-34. PubMed ID: 19212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in dogs.
    Pocchiari F; Pataccini R; Castelnovo P; Longo A; Paro M; Casagrande C
    Arzneimittelforschung; 1986 Feb; 36(2A):341-4. PubMed ID: 3707646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of 3-methoxyamphetamine in dog, monkey and man.
    Midha KK; Cooper JK; Bailey K; Hubbard JW
    Xenobiotica; 1981 Feb; 11(2):137-46. PubMed ID: 6894510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of methoxyphenamine in man and in monkey.
    Midha KK; Cooper JK; Mcgilveray IJ; Coutts RT; Dawe R
    Drug Metab Dispos; 1976; 4(6):568-76. PubMed ID: 11979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and chemical properties of ibopamine and of related esters of N-substituted dopamines--synthesis of ibopamine metabolites.
    Casagrande C; Santangelo F; Saini C; Doggi F; Gerli F; Cerri O
    Arzneimittelforschung; 1986 Feb; 36(2A):291-303. PubMed ID: 3707640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of epinine 3-O-sulphate and 4-O-sulphate.
    Ferrini R; Merlo L; Miragoli G
    Arch Int Pharmacodyn Ther; 1987 Sep; 289(1):37-45. PubMed ID: 3435204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a nitrone as an in vitro metabolite of N-methylamphetamine.
    Coutts RT; Jones GR; Liu SF
    Biomed Mass Spectrom; 1978 Jun; 5(6):418-22. PubMed ID: 678611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo phenolic metabolites of N-alkylamphetamines in the rat. Evidence in favor of catechol formation.
    Coutts RT; Dawson GW; Kazakoff CW; Wong JY
    Drug Metab Dispos; 1976; 4(3):256-61. PubMed ID: 6230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of 4-O-methyldopamine in rat tissues by reverded-phase liquid chromatography (author's transl)].
    Bidard JN; Cronenberger L
    J Chromatogr; 1979 Oct; 164(2):139-54. PubMed ID: 541405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in rats.
    Pocchiari F; Pataccini R; Castelnovo P; Longo A; Casagrande C
    Arzneimittelforschung; 1986 Feb; 36(2A):334-40. PubMed ID: 3707645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma detection by enzyme-radioimmunoassay of L-dopa, dopamine, and 3-O-methyldopamine in urine.
    Faraj BA; Lawson DH; Nixon DW; Murray DR; Camp VM; Ali FM; Black M; Stacciarini W; Tarcan Y
    Clin Chem; 1981 Jan; 27(1):108-12. PubMed ID: 7004664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometry.
    de Boer D; Tan LP; Gorter P; van de Wal RM; Kettenes-van den Bosch JJ; de Bruijn EA; Maes RA
    J Mass Spectrom; 1997 Nov; 32(11):1236-46. PubMed ID: 9373962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of alpha-methyldopamine ("Catecholamphetamine") from p-hydroxyamphetamine by rat brain microsomes.
    Hoffman AR; Sastry BV; Axelrod J
    Pharmacology; 1979; 19(5):256-60. PubMed ID: 538080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Alkyl derivatives of (+/-)-alpha-methyldopamine.
    Cannon JG; Perez Z; Long JP; Rusterholz DB; Flynn JR; Costall B; Fortune DH; Naylor RJ
    J Med Chem; 1979 Aug; 22(8):901-7. PubMed ID: 573798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic disposition of laudanosine in dog, rabbit, and man.
    Canfell PC; Castagnoli N; Fahey MR; Hennis PJ; Miller RD
    Drug Metab Dispos; 1986; 14(6):703-8. PubMed ID: 2877830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.